跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DBL MORPHINE SULFATE 30mg/1mL injection ampoule - TGA Drug Approval Details
Approvals
/
TGA
/
DBL MORPHINE SULFATE 30mg/1mL injection ampoule
Approved
STANDARD
DBL MORPHINE SULFATE 30mg/1mL injection ampoule
Pfizer Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
4be2b11a386bf3d4
Company
Pfizer Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
4be2b11a386bf3d4
Product Name
DBL MORPHINE SULFATE 30mg/1mL injection ampoule
Artg Id
121755
Artg Name
DBL MORPHINE SULFATE 30mg/1mL injection ampoule
Sponsor
Pfizer Australia Pty Ltd
Company Detail Path
/organization/pfizer-australia-pty-ltd
Artg Date
2005-12-22
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2018-CMI-02012-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2018-PI-02011-1
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
4be2b11a386bf3d4
Type
Standard
Back to TGA Approvals